OmniaBio
Meetkumar Patel is an experienced professional in the chemical engineering field, currently serving as Associate II in Manufacturing at OmniaBio since March 2024. Prior to this role, Meetkumar worked at Novocol Pharma from January 2021 to March 2024, initially as a Filling Specialist and later as a Filling Operator. Meetkumar also gained valuable experience at CTX Lifesciences in early 2019 as a Trainee Officer, focusing on the experimentation and validation of APIs for yield improvement. Additionally, a brief vocational training at Lupin Limited in June 2017 provided insights into the manufacturing processes of Tartaric Acid, an intermediate for the Ethambutol anti-TB drug. Meetkumar holds a Master of Engineering in Chemical Engineering from the University of Waterloo and a Bachelor of Engineering in Chemical Engineering from Sarvajanik College of Engineering & Technology.
This person is not in any teams
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.